143 related articles for article (PubMed ID: 33190003)
1. IL-33 synergistically promotes the proliferation of lung cancer cells in vitro by inducing antibacterial peptide LL-37 and proinflammatory cytokines in macrophages.
Jiang Y; Liao H; Zhang X; Cao S; Hu X; Yang Z; Fang Y; Wang H
Immunobiology; 2020 Nov; 225(6):152025. PubMed ID: 33190003
[TBL] [Abstract][Full Text] [Related]
2. Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways.
Yu J; Mookherjee N; Wee K; Bowdish DM; Pistolic J; Li Y; Rehaume L; Hancock RE
J Immunol; 2007 Dec; 179(11):7684-91. PubMed ID: 18025214
[TBL] [Abstract][Full Text] [Related]
3. Human cathelicidin LL-37 and its derivative IG-19 regulate interleukin-32-induced inflammation.
Choi KY; Napper S; Mookherjee N
Immunology; 2014 Sep; 143(1):68-80. PubMed ID: 24666281
[TBL] [Abstract][Full Text] [Related]
4. Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway.
Pistolic J; Cosseau C; Li Y; Yu JJ; Filewod NC; Gellatly S; Rehaume LM; Bowdish DM; Hancock RE
J Innate Immun; 2009; 1(3):254-67. PubMed ID: 20375583
[TBL] [Abstract][Full Text] [Related]
5. Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses.
Brown KL; Poon GF; Birkenhead D; Pena OM; Falsafi R; Dahlgren C; Karlsson A; Bylund J; Hancock RE; Johnson P
J Immunol; 2011 May; 186(9):5497-505. PubMed ID: 21441450
[TBL] [Abstract][Full Text] [Related]
6. Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs.
Nijnik A; Pistolic J; Wyatt A; Tam S; Hancock RE
J Immunol; 2009 Nov; 183(9):5788-98. PubMed ID: 19812202
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory Cytokines Impair Vitamin D-Induced Host Defense in Cultured Airway Epithelial Cells.
Schrumpf JA; Amatngalim GD; Veldkamp JB; Verhoosel RM; Ninaber DK; Ordonez SR; van der Does AM; Haagsman HP; Hiemstra PS
Am J Respir Cell Mol Biol; 2017 Jun; 56(6):749-761. PubMed ID: 28231019
[TBL] [Abstract][Full Text] [Related]
8. Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide.
Bommineni YR; Pham GH; Sunkara LT; Achanta M; Zhang G
Mol Immunol; 2014 May; 59(1):55-63. PubMed ID: 24491488
[TBL] [Abstract][Full Text] [Related]
9. LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature.
van der Does AM; Beekhuizen H; Ravensbergen B; Vos T; Ottenhoff TH; van Dissel JT; Drijfhout JW; Hiemstra PS; Nibbering PH
J Immunol; 2010 Aug; 185(3):1442-9. PubMed ID: 20610648
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages.
Cha HR; Lee JH; Hensel JA; Sawant AB; Davis BH; Lee CM; Deshane JS; Ponnazhagan S
Prostate; 2016 May; 76(7):624-36. PubMed ID: 26856684
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial peptide LL-37 attenuates LTA induced inflammatory effect in macrophages.
Ruan Y; Shen T; Wang Y; Hou M; Li J; Sun T
Int Immunopharmacol; 2013 Mar; 15(3):575-80. PubMed ID: 23375934
[TBL] [Abstract][Full Text] [Related]
12. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling.
Ji P; Zhou Y; Yang Y; Wu J; Zhou H; Quan W; Sun J; Yao Y; Shang A; Gu C; Zeng B; Firrman J; Xiao W; Bals R; Sun Z; Li D
Theranostics; 2019; 9(8):2209-2223. PubMed ID: 31149039
[No Abstract] [Full Text] [Related]
13. Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease.
Kusaka S; Nishida A; Takahashi K; Bamba S; Yasui H; Kawahara M; Inatomi O; Sugimoto M; Andoh A
Clin Exp Immunol; 2018 Jan; 191(1):96-106. PubMed ID: 28872665
[TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial peptide LL-37 in macrophages promotes colorectal cancer growth].
Pan XH; Quan WW; Wu JL; Xiao WD; Sun ZJ; Li D
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):412-417. PubMed ID: 29936765
[No Abstract] [Full Text] [Related]
15. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.
Coffelt SB; Marini FC; Watson K; Zwezdaryk KJ; Dembinski JL; LaMarca HL; Tomchuck SL; Honer zu Bentrup K; Danka ES; Henkle SL; Scandurro AB
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3806-11. PubMed ID: 19234121
[TBL] [Abstract][Full Text] [Related]
16. Expression and Purification of Hybrid LL-37Tα1 Peptide in
Ahmad B; Hanif Q; Xubiao W; Lulu Z; Shahid M; Dayong S; Rijun Z
Front Immunol; 2019; 10():1365. PubMed ID: 31258535
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice.
Hu Z; Murakami T; Suzuki K; Tamura H; Reich J; Kuwahara-Arai K; Iba T; Nagaoka I
Int Immunol; 2016 May; 28(5):245-53. PubMed ID: 26746575
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of IL-33 in rosacea skin and UVB-irradiated and LL-37-treated HaCaT cells.
Suhng E; Kim BH; Choi YW; Choi HY; Cho H; Byun JY
Exp Dermatol; 2018 Sep; 27(9):1023-1029. PubMed ID: 29873850
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial and immunomodulatory activity of host defense peptides, clavanins and LL-37, in vitro: An endodontic perspective.
Lima SMF; Freire MS; Gomes ALO; Cantuária APC; Dutra FRP; Magalhães BS; Sousa MGC; Migliolo L; Almeida JA; Franco OL; Rezende TMB
Peptides; 2017 Sep; 95():16-24. PubMed ID: 28712894
[TBL] [Abstract][Full Text] [Related]
20. A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.
Zhang J; Jiang P; Sheng L; Liu Y; Liu Y; Li M; Tao M; Hu L; Wang X; Yang Y; Xu Y; Liu W
Front Immunol; 2021; 12():609615. PubMed ID: 34322115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
